搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Putative nrdI-like protein (SP_0158) CSB-YP853695FMW
CSB-EP853695FMW
CSB-BP853695FMW
CSB-MP853695FMW
CSB-EP853695FMW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifunctional purine biosynthesis protein PurH (purH), partial CSB-YP853696FMW
CSB-EP853696FMW
CSB-BP853696FMW
CSB-MP853696FMW
CSB-EP853696FMW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Fructose-bisphosphate aldolase class 1 (fda) CSB-YP853697DUB
CSB-EP853697DUB
CSB-BP853697DUB
CSB-MP853697DUB
CSB-EP853697DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Protease HtpX homolog 2 (htpX2), partial CSB-YP853698FPM1
CSB-EP853698FPM1
CSB-BP853698FPM1
CSB-MP853698FPM1
CSB-EP853698FPM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Glucose 1-dehydrogenase 2 (gdh2) CSB-YP853699FPM
CSB-EP853699FPM
CSB-BP853699FPM
CSB-MP853699FPM
CSB-EP853699FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Triosephosphate isomerase (tpiA) CSB-YP853700FPM
CSB-EP853700FPM
CSB-BP853700FPM
CSB-MP853700FPM
CSB-EP853700FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Endonuclease V (nfi) CSB-YP853701FPM
CSB-EP853701FPM
CSB-BP853701FPM
CSB-MP853701FPM
CSB-EP853701FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Ribonuclease HII (rnhB) CSB-YP853702FPM
CSB-EP853702FPM
CSB-BP853702FPM
CSB-MP853702FPM
CSB-EP853702FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Bifunctional phosphoglucose/phosphomannose isomerase (SSO2281) CSB-YP853703FPM
CSB-EP853703FPM
CSB-BP853703FPM
CSB-MP853703FPM
CSB-EP853703FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Ribosomal RNA small subunit methyltransferase Nep1 (nep1) CSB-YP853704FPM
CSB-EP853704FPM
CSB-BP853704FPM
CSB-MP853704FPM
CSB-EP853704FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Nucleoside-triphosphatase THEP1 (SSO2171) CSB-YP853705FPM
CSB-EP853705FPM
CSB-BP853705FPM
CSB-MP853705FPM
CSB-EP853705FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Protease HtpX homolog 1 (htpX1), partial CSB-YP853706FPM1
CSB-EP853706FPM1
CSB-BP853706FPM1
CSB-MP853706FPM1
CSB-EP853706FPM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Putative esterase SSO1253 (SSO1253) CSB-YP853707FPM
CSB-EP853707FPM
CSB-BP853707FPM
CSB-MP853707FPM
CSB-EP853707FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus DNA polymerase sliding clamp C (pcnC) CSB-YP853708FPM
CSB-EP853708FPM
CSB-BP853708FPM
CSB-MP853708FPM
CSB-EP853708FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Uncharacterized solute-binding protein SSO1031 (SSO1031) CSB-YP853709FPM
CSB-EP853709FPM
CSB-BP853709FPM
CSB-MP853709FPM
CSB-EP853709FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Type 2 DNA topoisomerase 6 subunit B (top6B), partial CSB-YP853710FPM
CSB-EP853710FPM
CSB-BP853710FPM
CSB-MP853710FPM
CSB-EP853710FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Putative HTH-type transcriptional regulatory protein SSO0942 (SSO0942) CSB-YP853711FPM
CSB-EP853711FPM
CSB-BP853711FPM
CSB-MP853711FPM
CSB-EP853711FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Probable N-glycosylase/DNA lyase (ogg) CSB-YP853712FPM
CSB-EP853712FPM
CSB-BP853712FPM
CSB-MP853712FPM
CSB-EP853712FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus 30S ribosomal protein S14P type Z (rps14p) CSB-YP853713FPM
CSB-EP853713FPM
CSB-BP853713FPM
CSB-MP853713FPM
CSB-EP853713FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Putative ribose 1,5-bisphosphate isomerase (SSO0436) CSB-YP853714FPM
CSB-EP853714FPM
CSB-BP853714FPM
CSB-MP853714FPM
CSB-EP853714FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>